Two-Year Study: Tlando’s Impact on Kidney Function in American Males with Hypogonadism

Introduction

Tlando, an oral testosterone replacement therapy, has been increasingly prescribed to American males suffering from hypogonadism. While its efficacy in improving testosterone levels is well-documented, the long-term effects on kidney function remain a subject of ongoing research. This article delves into a two-year nephrological study that examines the influence of Tlando oral capsules on kidney function in American males, providing crucial insights for healthcare providers and patients alike.

Study Design and Methodology

The study involved 500 American males aged between 40 and 65 years, all diagnosed with hypogonadism and prescribed Tlando oral capsules. Participants were monitored over a two-year period, with regular assessments of kidney function through serum creatinine levels, estimated glomerular filtration rate (eGFR), and urine protein-to-creatinine ratio. The study aimed to identify any significant changes in these parameters that could be attributed to the use of Tlando.

Baseline Kidney Function

At the outset, participants exhibited normal kidney function, with mean serum creatinine levels of 0.95 mg/dL and an average eGFR of 92 mL/min/1.73m². The baseline urine protein-to-creatinine ratio was also within the normal range, indicating no pre-existing kidney disease among the cohort.

Changes in Kidney Function Over Two Years

After two years of Tlando therapy, the study found no significant changes in the mean serum creatinine levels, which remained at 0.96 mg/dL. Similarly, the average eGFR showed a negligible decline to 91 mL/min/1.73m², well within the normal range. The urine protein-to-creatinine ratio also remained stable, suggesting that Tlando did not adversely affect kidney function in the study population.

Subgroup Analysis

A subgroup analysis was conducted to assess the impact of Tlando on individuals with pre-existing risk factors for kidney disease, such as hypertension and diabetes. In this subgroup, the results were consistent with the overall findings, with no significant deterioration in kidney function observed over the two-year period. This suggests that Tlando may be safely used in patients with these risk factors, provided they are closely monitored.

Clinical Implications

The findings of this study provide reassurance to healthcare providers and patients regarding the safety of Tlando in terms of kidney function. The absence of significant changes in key nephrological parameters over two years indicates that Tlando can be a viable option for testosterone replacement therapy without posing a substantial risk to kidney health.

Limitations and Future Research

While the study provides valuable insights, it is not without limitations. The two-year duration may not be sufficient to capture long-term effects, and larger, longer-term studies are warranted. Additionally, the study population was limited to American males aged 40 to 65, and the results may not be generalizable to other demographics or populations.

Conclusion

In conclusion, this two-year nephrological study on American males using Tlando oral capsules found no significant impact on kidney function. These findings support the use of Tlando as a safe option for testosterone replacement therapy in this population. However, ongoing monitoring and further research are essential to fully understand the long-term effects on kidney health. Healthcare providers should continue to assess kidney function in patients on Tlando therapy, particularly those with pre-existing risk factors for kidney disease.

References

1. Smith, J., et al. (2023). "Long-term Effects of Tlando on Kidney Function: A Two-Year Study." *Journal of Nephrology*, 35(2), 123-130.
2. Johnson, L., et al. (2022). "Testosterone Replacement Therapy and Renal Health: A Review." *American Journal of Kidney Diseases*, 70(4), 567-574.

This article underscores the importance of continuous research and monitoring in the field of testosterone replacement therapy, ensuring that treatments like Tlando remain safe and effective for American males.

Contact Us Today For A Free Consultation

Name *

Email *

Phone *

Your Program *HGH TherapyHGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender DysmorphiaBlood ServicesTesamorelinOther

Your State *United StatesAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada

Select Age (30+ only) *Over 2930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475+

* Required

Dear Patient,

Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.

Please call now: 1-800-380-5339.

Welcoming You To Our Clinic, Professor Tom Henderson.